Svai Sanford
2020
In 2020, Svai Sanford earned a total compensation of $519.8K as Chief Financial Officer at Rani Therapeutics Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $140,000 |
|---|---|
| Option Awards | $77,200 |
| Salary | $302,564 |
| Total | $519,764 |
Sanford received $302.6K in salary, accounting for 58% of the total pay in 2020.
Sanford also received $140K in non-equity incentive plan and $77.2K in option awards.
Rankings
In 2020, Svai Sanford's compensation ranked 10,925th out of 13,090 executives tracked by ExecPay. In other words, Sanford earned more than 16.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,925 out of 13,090 | 17th |
Division Manufacturing | 4,664 out of 5,624 | 17th |
Major group Chemicals And Allied Products | 1,936 out of 2,257 | 14th |
Industry group Drugs | 1,696 out of 1,957 | 13th |
Industry Pharmaceutical Preparations | 1,253 out of 1,462 | 14th |
Source: SEC filing on April 13, 2022.
Sanford's colleagues
We found one more compensation record of an executive who worked with Svai Sanford at Rani Therapeutics Holdings in 2020.
2020
Mir Hashim
Rani Therapeutics Holdings